Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants with headaches that meet the diagnostic criteria for migraines according to the International Classification of Headache Disorders, 3rd edition (ICHD-3), with or without aura.
Patients prescribed rimegepant by the attending physician for the treatment of migraines.
Signed informed consent form.
Age greater than 18 years.
Not concurrently participating in other interventional clinical studies.
You may not be if
Patients diagnosed with secondary headaches.
Patients with severe visual, auditory, language, intellectual, memory, consciousness impairments or other conditions that prevent them from completing the questionnaire and follow-up.
Pregnant or lactating female patients.
Patients deemed by the investigator as unsuitable for participation in the study or unable to complete the 4-week follow-up.
Patients with a known history of hypersensitivity reactions to rimegepant or its components.
Evidence in the medical history suggesting the presence of uncontrolled or unstable cardiovascular diseases (such as ischemic heart disease, coronary artery vasospasm, or cerebrovascular ischemia), or a history of myocardial infarction, acute coronary syndrome, percutaneous coronary intervention, cardiac surgery, stroke, or transient ischemic attack within the past 6 months before the screening visit.
